The global antibody
production market is expected to reach a value of USD 22.6 billion by
2025, according to a new report by Grand View Research, Inc. Increasing demand
for therapeutic antibodies including monoclonal and polyclonal antibodies is a
major factor that drives growth of the market during forecast period.
Antibodies are the dominant biopharmaceuticals that specifically target the
abnormal cells. Thus, many pharmaceuticals and biotechnology companies have
begun to focus on the development of advanced antibodies for the treatment of
chronic diseases such as cancer, rheumatic heart disease, and arthritis.
Patent expiry of several blockbuster monoclonal antibodies
in the near future, is another major factor supporting the growth of the
antibody production market. Several antibodies such as Avastin, Herceptin, and
Mabthera are going to lose their patents in a few years. For instance, the
patent of Herceptin (trastuzumab) expired in Europe in July 2014 and will
expire in the U.S. in June 2019. Many companies such as Amgen Inc., Synthon,
Biocon, and Pfizer Inc. are developing biosimilar for trastuzumab, which is
expected to propel the demand for antibody production products.
Browse full research report on Antibody Production Market: https://www.grandviewresearch.com/industry-analysis/antibody-production-market
Further
key findings from the study suggest:
- Downstream processing was the largest revenue-grossing segment of
the antibody production market in 2016. It is also expected to exhibit the
highest CAGR during the forecast period, owing to large application of
chromatography devices and resins in downstream processing
- The monoclonal antibody segment was leading in 2016, due to its
higher demand in treatment of chronic diseases including cancer, blood
disorders, and growth hormone deficiency
- The pharmaceutical and biotechnology companies segment dominated
the overall market in terms of revenue in 2016, owing to the large
production of therapeutic antibodies and high investment in R&D by
companies for drug development
- North America was the largest revenue-generating region of the
market in the year 2016. This region is expected to maintain its position
during the forecast period because of the presence of several leading
biopharmaceuticals and biotechnology companies in this region
- Asia Pacific region is projected to be the fastest-growing segment
over the study period, due to rapidly booming biotechnology industry and
comparatively less stringent regulations for biologics development in APAC
region
- Some of the key players include GE Healthcare; Thermo Fisher
Scientific, Inc.; Sartorius AG; Merck KGaA; Pall Corp.; Eppendorf AG;
Cellab GmbH; INTEGRA Biosciences AG; and FiberCell Systems Inc.
Browse more reports of this category
by Grand View Research: https://www.grandviewresearch.com/industry/biotechnology
Grand
View Research has segmented the antibody production market on the basis of
type, process, end-use, and region:
Antibody
Production Type Outlook (Revenue, USD Million; 2014 - 2025)
- Polyclonal
antibody
- Monoclonal
antibody
- Murine
- Chimeric
- Humanized
Antibody
Production Process Outlook (Revenue, USD Million; 2014 - 2025)
- Upstream
processing
- Bioreactors
- Largescale
bioreactors
- Single-use
bioreactors
- Consumables
- Media
- Buffers and
reagents
- Downstream
processing
- Chromatography
systems
- Chromatography
resins
- Filtration
- Filtration
systems
- Filtration
consumables and accessories
Antibody
Production End-Use Outlook (Revenue, USD Million; 2014 - 2025)
- Pharmaceutical
and biotechnology companies
- Research
laboratories
- Others
Antibody
Production Regional Outlook (Revenue, USD Million; 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment